Literature DB >> 20021352

Sigma-1 receptor chaperones and diseases.

Shang-Yi Tsai1, Teruo Hayashi, Tomohisa Mori, Tsung-Ping Su.   

Abstract

Chaperones are proteins that assist the correct folding of other protein clients either when the clients are being synthesized or at their functional localities. Chaperones are responsible for certain diseases. The sigma-1 receptor is recently identified as a receptor chaperone whose activity can be activated/deactivated by specific ligands. Under physiological conditions, the sigma-1 receptor chaperones the functional IP3 receptor at the endoplasmic reticulum and mitochondrion interface to ensure proper Ca(2+) signaling from endoplasmic reticulum into mitochondrion. However, under pathological conditions whereby cells encounter enormous stress that results in the endoplasmic reticulum losing its global Ca(2+) homeostasis, the sigma-1 receptor translocates and counteracts the arising apoptosis. Thus, the sigma-1 receptor is a receptor chaperone essential for the metabotropic receptor signaling and for the survival against cellular stress. The sigma-1 receptor has been implicated in many diseases including addiction, pain, depression, stroke, and cancer. Whether the chaperone activity of the sigma-1 receptor attributes to those diseases awaits further investigation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20021352      PMCID: PMC3150837          DOI: 10.2174/1871524910909030184

Source DB:  PubMed          Journal:  Cent Nerv Syst Agents Med Chem        ISSN: 1871-5249


  63 in total

Review 1.  Biosynthetic regulation and intracellular transport of phosphatidylserine in mammalian cells.

Authors:  Osamu Kuge; Masahiro Nishijima
Journal:  J Biochem       Date:  2003-04       Impact factor: 3.387

Review 2.  A trip to the ER: coping with stress.

Authors:  D Thomas Rutkowski; Randal J Kaufman
Journal:  Trends Cell Biol       Date:  2004-01       Impact factor: 20.808

Review 3.  SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants.

Authors:  Stephen M Stahl; Meghan M Grady; Chantal Moret; Mike Briley
Journal:  CNS Spectr       Date:  2005-09       Impact factor: 3.790

4.  Formalin-induced pain is reduced in sigma(1) receptor knockout mice.

Authors:  Cruz Miguel Cendán; José Miguel Pujalte; Enrique Portillo-Salido; Lluís Montoliu; José M Baeyens
Journal:  Eur J Pharmacol       Date:  2005-03-21       Impact factor: 4.432

5.  Mechanism of proteasomal degradation of inositol trisphosphate receptors in CHO-K1 cells.

Authors:  Cunnigaiper D Bhanumathy; Steven K Nakao; Suresh K Joseph
Journal:  J Biol Chem       Date:  2005-11-29       Impact factor: 5.157

Review 6.  Sigma(1) (sigma(1)) receptor antagonists represent a new strategy against cocaine addiction and toxicity.

Authors:  Tangui Maurice; Rémi Martin-Fardon; Pascal Romieu; Rae R Matsumoto
Journal:  Neurosci Biobehav Rev       Date:  2002-06       Impact factor: 8.989

7.  Potent sigma1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine modulates basal and N-methyl-D-aspartate-evoked nitric oxide production in vivo.

Authors:  A Bhardwaj; M Sawada; E D London; R C Koehler; R J Traystman; J R Kirsch
Journal:  Stroke       Date:  1998-11       Impact factor: 7.914

8.  Neuroleptics antagonize nalbuphine antianalgesia.

Authors:  Robert W Gear; Janice S Lee; Christine Miaskowski; Newton C Gordon; Steven M Paul; Jon D Levine
Journal:  J Pain       Date:  2006-03       Impact factor: 5.820

9.  Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis.

Authors:  Marissa V Powers; Paul A Clarke; Paul Workman
Journal:  Cancer Cell       Date:  2008-09-09       Impact factor: 31.743

Review 10.  Behavioral pharmacology of sigma-ligands.

Authors:  G Skuza; K Wedzony
Journal:  Pharmacopsychiatry       Date:  2004-11       Impact factor: 5.788

View more
  41 in total

1.  Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization.

Authors:  L Romero; D Zamanillo; X Nadal; R Sánchez-Arroyos; I Rivera-Arconada; A Dordal; A Montero; A Muro; A Bura; C Segalés; M Laloya; E Hernández; E Portillo-Salido; M Escriche; X Codony; G Encina; J Burgueño; M Merlos; J M Baeyens; J Giraldo; J A López-García; R Maldonado; C R Plata-Salamán; J M Vela
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

Review 2.  Sigma receptors: potential targets for a new class of antidepressant drug.

Authors:  James A Fishback; Matthew J Robson; Yan-Tong Xu; Rae R Matsumoto
Journal:  Pharmacol Ther       Date:  2010-05-11       Impact factor: 12.310

3.  Effects of the selective sigma receptor ligand, 1-(2-phenethyl)piperidine oxalate (AC927), on the behavioral and toxic effects of cocaine.

Authors:  Rae R Matsumoto; Su-Min Li; Jonathan L Katz; William E Fantegrossi; Andrew Coop
Journal:  Drug Alcohol Depend       Date:  2011-03-21       Impact factor: 4.492

4.  Neuroprotective targets through which 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a sigma receptor ligand, mitigates the effects of methamphetamine in vitro.

Authors:  Nidhi Kaushal; Matthew J Robson; Abagail Rosen; Christopher R McCurdy; Rae R Matsumoto
Journal:  Eur J Pharmacol       Date:  2013-12-28       Impact factor: 4.432

Review 5.  Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders.

Authors:  Shang-Yi A Tsai; Michael J Pokrass; Neal R Klauer; Nicole E De Credico; Tsung-Ping Su
Journal:  Expert Opin Ther Targets       Date:  2014-10-21       Impact factor: 6.902

Review 6.  Sigma-1 Receptors and Neurodegenerative Diseases: Towards a Hypothesis of Sigma-1 Receptors as Amplifiers of Neurodegeneration and Neuroprotection.

Authors:  Linda Nguyen; Brandon P Lucke-Wold; Shona Mookerjee; Nidhi Kaushal; Rae R Matsumoto
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

7.  Characterization of recombinant ELMOD (cell engulfment and motility domain) proteins as GTPase-activating proteins (GAPs) for ARF family GTPases.

Authors:  Anna A Ivanova; Michael P East; Slee L Yi; Richard A Kahn
Journal:  J Biol Chem       Date:  2014-03-10       Impact factor: 5.157

8.  A direct interaction between the sigma-1 receptor and the hERG voltage-gated K+ channel revealed by atomic force microscopy and homogeneous time-resolved fluorescence (HTRF®).

Authors:  Dilshan Balasuriya; Lauren D'Sa; Ronel Talker; Elodie Dupuis; Fabrice Maurin; Patrick Martin; Franck Borgese; Olivier Soriani; J Michael Edwardson
Journal:  J Biol Chem       Date:  2014-09-29       Impact factor: 5.157

9.  Sigma-1 receptors modulate neonatal Nav1.5 ion channels in breast cancer cell lines.

Authors:  Ebru Aydar; Dan Stratton; Scott P Fraser; Mustafa B A Djamgoz; Christopher Palmer
Journal:  Eur Biophys J       Date:  2016-05-09       Impact factor: 1.733

10.  Sigma-2 Receptors Play a Role in Cellular Metabolism: Stimulation of Glycolytic Hallmarks by CM764 in Human SK-N-SH Neuroblastoma.

Authors:  Hilary Nicholson; Christophe Mesangeau; Christopher R McCurdy; Wayne D Bowen
Journal:  J Pharmacol Exp Ther       Date:  2015-11-16       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.